Gregory R Pond
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel
Sonpavde G, Pond G, Templeton A, Fandi A, Tombal B, Rosenthal M, Armstrong A, Petrylak D. Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel. Eur Urol 2015
20.10.2015Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel
20.10.2015Eur Urol 2015
Sonpavde Guru, Pond Gregory R, Templeton Arnoud, Fandi Abderrahim, Tombal Bertrand, Rosenthal Mark, Armstrong Andrew J, Petrylak Daniel P
Influence of censoring on conclusions of trials for women with metastatic breast cancer
Templeton A, Ace O, Amir E, Vera-Badillo F, Ocana A, Pond G, Tannock I. Influence of censoring on conclusions of trials for women with metastatic breast cancer. Eur J Cancer 2015
26.02.2015Influence of censoring on conclusions of trials for women with metastatic breast cancer
26.02.2015Eur J Cancer 2015
Templeton Arnoud, Ace Olga, Amir Eitan, Vera-Badillo Francisco, Ocana Alberto, Pond Gregory R, Tannock Ian F
Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis
Rocha P, Morgan C, Templeton A, Pond G, Naik G, Sonpavde G. Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis. Oncol Res Treat 2014; 37:772-6.
20.11.2014Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis
20.11.2014Oncol Res Treat 2014; 37:772-6
Rocha Pedro, Morgan Charity J, Templeton Arnoud, Pond Gregory R, Naik Gurudatta, Sonpavde Guru
Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer
Sonpavde G, Smith M, Lechuga M, Chow-Maneval E, Chen I, Paolini J, Wang S, Templeton A, Vardy J, Clarke S, Armstrong A, Pond G, Michaelson M. Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer 2014; 12:317-24.
15.03.2014Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer
15.03.2014Clin Genitourin Cancer 2014; 12:317-24
Sonpavde Guru, Smith Matthew R, Lechuga Mariajose, Chow-Maneval Edna, Chen Isan, Paolini Jolanda, Wang Shaw-Ling, Templeton Arnoud, Vardy Janette L, Clarke Stephen J, Armstrong Andrew J, Pond Gregory R, Michaelson M Dror